PAD4 Antikörper (Middle Region)
-
- Target Alle PAD4 (PADI4) Antikörper anzeigen
- PAD4 (PADI4) (Peptidyl Arginine Deiminase, Type IV (PADI4))
-
Bindungsspezifität
- Middle Region
- Reaktivität
- Human, Ratte, Maus, Kaninchen, Schaf, Zebrafisch (Danio rerio), Rind (Kuh), Hund, Meerschweinchen, Pferd, Schwein
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser PAD4 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Sequenz
- TGGISGLDSF GNLEVSPPVT VRGKEYPLGR ILFGDSCYPS NDSRQMHQAL
- Homologie
- Cow: 93%, Dog: 100%, Guinea Pig: 87%, Horse: 93%, Human: 100%, Mouse: 100%, Pig: 93%, Rabbit: 86%, Rat: 100%, Sheep: 79%, Zebrafish: 86%
- Produktmerkmale
- This is a rabbit polyclonal antibody against PADI4. It was validated on Western Blot using a cell lysate as a positive control.
- Aufreinigung
- Affinity Purified
- Immunogen
- The immunogen is a synthetic peptide directed towards the middle region of human PADI4
- Top Product
- Discover our top product PADI4 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilutions should be determined experimentally by the investigator.
- Kommentare
-
Antigen size: 663 AA
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- Lot specific
- Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
Genetic polymorphisms in PTPN22, PADI-4, and CTLA-4 and risk for rheumatoid arthritis in two longitudinal cohort studies: evidence of gene-environment interactions with heavy cigarette smoking." in: Arthritis research & therapy, Vol. 10, Issue 3, pp. R52, (2008) (PubMed).
: "
-
Genetic polymorphisms in PTPN22, PADI-4, and CTLA-4 and risk for rheumatoid arthritis in two longitudinal cohort studies: evidence of gene-environment interactions with heavy cigarette smoking." in: Arthritis research & therapy, Vol. 10, Issue 3, pp. R52, (2008) (PubMed).
-
- Target
- PAD4 (PADI4) (Peptidyl Arginine Deiminase, Type IV (PADI4))
- Andere Bezeichnung
- PADI4 (PADI4 Produkte)
- Synonyme
- PAD antikoerper, PAD4 antikoerper, PADI5 antikoerper, PDI4 antikoerper, PDI5 antikoerper, Pad4 antikoerper, Pdi4 antikoerper, peptidyl arginine deiminase 4 antikoerper, peptidyl arginine deiminase, type IV antikoerper, PADI4 antikoerper, Padi4 antikoerper
- Hintergrund
-
PADI4 is an enzyme responsible for the conversion of arginine residues to citrulline residues. This protein may play a role in granulocyte and macrophage development leading to inflammation and immune response.This gene is a member of a gene family which encodes enzymes responsible for the conversion of arginine residues to citrulline residues. This gene may play a role in granulocyte and macrophage development leading to inflammation and immune response. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.
Alias Symbols: PAD, PADI5, PDI4, PDI5, PAD4
Protein Interaction Partner: ANXA4, FBXO25, APP, ING4, ELK1, NPM1, TP53, HDAC2, HIST2H3A, HDAC1, TFF1, HIST4H4, HIST3H3,
Protein Size: 663 - Molekulargewicht
- 74 kDa
- Gen-ID
- 23569
- NCBI Accession
- NM_012387, NP_036519
- UniProt
- Q9UM07
-